GSK plc (OTC Pink - Current Information:GLAXF)
| 17.90 Delayed Data As of Dec 08 |  +0.14 / +0.79%Today’s Change | 16.34 Today|||52-Week Range 19.60 | +2.37% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Revenue and Income | Net Revenues | 10.5B | 10.5B | 10.0B | 10.0B | |
| Cost of Goods Sold | 2.8B | 3.0B | 1.6B | 2.1B | ||
| Depreciation And Amortization | 646.4M | 764.1M | 1.5B | 997.3M | ||
| Operating Expenses | Gross Income | 7.1B | 6.8B | 6.9B | 6.9B | |
| General Expenses | 4.6B | 4.8B | 4.5B | 4.6B | ||
| Research And Development | 1.3B | 1.4B | 1.3B | 1.4B | ||
| Total Operating Expenses | 8.0B | 8.5B | 7.6B | 7.8B | ||
| Non-Operating Expenses | Operating Income | 2.5B | 2.1B | 2.4B | 2.3B | |
| Extraordinary Credit | 0.00 | 0.00 | 110.7M | 0.00 | ||
| Extraordinary Charge | -323.2M | -294.6M | -494.9M | -638.8M | ||
| Interest Expense On Debt | 303.6M | 268.9M | 291.7M | 304.6M | ||
| Equity In Earnings | 19.5M | 6.4M | 74.2M | -5.1M | ||
| Other Expenses | 286.7M | 239.3M | -134.1M | 260.9M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 2.2B | 1.8B | 1.6B | 1.6B | |
| Income Taxes | -251.5M | -95.2M | -403.7M | -275.0M | ||
| Minority Interest | -122.5M | -109.3M | -201.9M | -110.5M | ||
| Net Income | 1.8B | 1.6B | 1.1B | 1.2B | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 4.9B | 4.9B | 4.9B | 4.9B | |
| Shares To Calculate EPS Diluted | 5.0B | 5.0B | 5.0B | 5.0B | ||
| Earnings Per Share | EPS | $0.38 | $0.32 | $0.22 | $0.25 | |
| EPS Diluted | $0.37 | $0.31 | $0.22 | $0.25 | ||
